Effect of Pre-medication in Pain Measures on Office Hysteroscopy

• Status: Unknown status
• Trial end date: 2019-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

Will be perform a RCT to compare pain measure on office hysteroscopy after pre-medication with oral analgesic. Patients will be alocate to oral sodic diclofenac, scopolamin or placebo. We will compare visual analog score of pain after the procedure.

Patients: patients with indication of office hysteroscopy to evaluate uterine intracavitary abnormality.

Interventions Group 1 (control) The patients will receive about 2 h prior to the procedure 2 placebo tablets.

Group 2 (diclofenac + scopolamine) The patients will receive about 2 h prior to the procedure 1 tablet of diclofenac sodium 50 mg and 1 tablet of scopolamine 2 mg.

Group 3 (diclofenac only). Patients will receive approximately 2 h prior to the procedure 1 tablet of diclofenac sodium 50 mg and 1 tablet of placebo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre
• Treatments: Diclofenac

Criteria

Inclusion Criteria:

1. indication of intrauterine evaluation

2. Abnormal uterine bleeding

3. post-menopause uterine bleeding

4. infertility

5. recurrent miscarriage

Exclusion Criteria:

1. stenosis of the external cervical orifice,

2. pelvic inflammatory disease,

3. suspected gestation or pregnancy,

4. active bleeding at the time of examination

5. contraindication to the use of the study medication, diclofenac sodium and scopolamine,